CONTACT US 01312268200

MBM Commercial maintains high listings in Legal 500 and Chambers 2018 rankings

MBM Commercial’s Corporate and Dispute Resolution Groups rank highly in this years Legal 500 and Chambers rankings.  The Corporate Group are listed in Band 4 for Corporate and Commercial: Edinburgh and Glasgow in Legal 500. “Under Kenny Mumford’s leadership, MBM Commercial has become a major player in the angel investment and venture capital arena, where it acts for investors and high-growth investee companies.” - Legal 500 “The firm is particularly well-known for its work in the technology sector (it has been active in the Scottish technology investment market for more than 12 years); it recently acted as a lead adviser...
Continue reading
  885 Hits
885 Hits

SME Finance Report issued by the Treasury Select Committee

An SME Finance Report has been issued by the Treasury Select Committee today evaluating what needs to be done in terms of addressing the deficiencies in the SME finance market. MBM Commercial’s Cat MacLean appeared before the Treasury Select Committee in May as an expert witness, providing evidence on SME finance at the Financial Services Tribunal. This Tribunal questioned the behaviour of the banks, particularly around resolving disputes and whether there is a need for a financial tribunal system. Cat MacLean heads up MBM’s Dispute Resolution Team, and has been litigating against large financial institutions since 2008. She is a...
Continue reading
  745 Hits
745 Hits

Crowdfunding and Nominee Shareholdings

crowdfunding
Crowdfunding’s use has grown significantly in recent years to the point where it is now a common method of fund raising for early stage and growth companies. The regulation around crowdfunding is still relatively new and the FCA opened a consultation on the rules around loan-based crowdfunding back in July of this year, an example of how rapidly crowdfunding is expanding. ‘Equity-based’ crowdfunding is the form that most will be familiar with. This is where the ‘crowd’ invests through a large amount of individuals, each investing a relatively small amount in return for shares. Crowdfunding can be an invaluable tool...
Continue reading
  589 Hits
589 Hits

New funding to support global fight against C. difficile

MBM Commercial recently assisted with Archangels’ investment in MGB Biopharma to support the global fight against C. difficile . A novel anti-bacterial agent which has been developed in Scotland by MGB Biopharma (MGB) for the treatment of Clostridium difficile infections, is to enter Phase II clinical trials following a newly-completed £1.3m fund raise from existing and new investors, supplementing a £2.7m grant awarded earlier this year by Innovate UK.  MGB’s lead drug, MGB-BP-3 was invented at the University of Strathclyde, Glasgow, and will now be tested in patients for the first time in the fight against Clostridium difficile-associated disease (CDAD)....
Continue reading
  531 Hits
531 Hits

Another year, another (Converge) Challenge

converge front cover
converge participants
Converge Challenge has been a fantastic programme this year with some truly inspiring businesses coming through the programme. We have been very lucky to be involved and impressed by the market research, commercial awareness and technological innovation demonstrated by the Converge Challenge participant companies. It has been a real pleasure working with the cohort on business plans and legal issues. As part of MBM Commercial’s sponsorship of the programme, our Alexander Lamley has been attending legal clinics to help the Converge companies identify and address early stage issues. As a start-up business there are some essential things to think about...
Continue reading
  634 Hits
634 Hits

Contact us

Invalid Input
Invalid Input
Invalid Input
Invalid Input
Invalid Input
You must confirm you have read and accept our Website Privacy Policy.
Invalid Input